References
Impaired cardiac systolic function, Tumor, tumour
SUPPRESSION, TUMOR, TUMORIGENICITY, ISCHEMIC HEART DISEASE, TUMOUR, IHD, HEART
Structural equation model of the relations between ICAM1, ADIPON, SCF and OSTEOPR. Ellipses depict latent variables or factors and squares manifest or measured variables. All effects (Beta-values italicized) and factor loadings are significant. The correlation between ALFA and BETA is insignificant (r = 0.18, t = 1.16, (Baseline characteristics of the study population at inclusion, divided into those on active supplementation of selenium and coenzyme QNote: ACEI: ACE inhibitors; ARB: Angiotensin receptor blockers; EF: Ejection fraction; IHD: Ischemic heart disease, NYHA: New York Heart Association functional class; SD: Standard Deviation. Note: Values are means ± SDs or frequency (percent). Note: Student’s unpaired two-sided Table presenting the correlation coefficient (r), and Note: BMI: Body Mass Index; MMP-1: Matrix metalloproteinase-1; MR-proADM: MR-proadrenomedullin; ST2: Soluble suppression of Tumorigenicity 2 protein; TWEAK: Tumor necrosis-factor-like Weak inducer of Apoptosis.Multiple correlations between ALFA, BETA and 14 variables of the total database.Note: CRP: C-reactive protein; IHD: Ischemic heart disease; Imp. Syst. Func.: Impaired cardiac systolic function; MMP1: Matrix Metalloproteinase 1; ST2: Suppression of Tumorigenicity 2; TWEAK: tumour necrosis-factor-like weak inducer of apoptosis.